Clinical trial

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

NCT04963608

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-07-01

PhaseN/A

Study timeline

Study start (estimated)2021-07-01Date precision: month

Registry last updated2021-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2-positive Advanced Breast Cancerunresolved

Interventions

InetetamabDRUG

Sponsors & collaborators

Zhiyong Yulead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04963608 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.